← Open Payments lookup

MASON JAHNKE: Open Payments

NPI 1457767246 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$863 in 39 payments from 8 companies in 2025. Trend: 2023 $1,149 · 2024 $706 · 2025 $863

Food & beverage: $863
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$258
Alkermes, Inc.7$164
Janssen Pharmaceuticals, Inc7$150
Neurocrine BioSciences, Inc.5$115
Teva Pharmaceuticals USA, Inc.3$77
ABBVIE INC.2$42
E.R. Squibb & Sons, L.L.C.2$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, REXULTI, INGREZZA, UZEDY, VRAYLAR, COBENFY.

Industry payments across NV — which companies pay providers there.